p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
about
Eurogin 2016 Roadmap: how HPV knowledge is changing screening practice.A Suggested Approach to Simplify and Improve Cervical Screening in the United States.Triage of HPV positive women in cervical cancer screening.Combined clinical and genetic testing algorithm for cervical cancer diagnosis.HPV-based cervical cancer screening- facts, fiction, and misperceptions.Outcomes in Women With Cytology Showing Atypical Squamous Cells of Undetermined Significance With vs Without Human Papillomavirus Testing.Triage of high-risk HPV positive women in cervical cancer screening.Management of high-risk HPV-positive women for detection of cervical (pre)cancer.Somatic Host Cell Alterations in HPV Carcinogenesis.Management algorithms for cervical cancer screening and precancer treatment for resource-limited settings.Why does cervical cancer occur in a state-of-the-art screening program?Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.[Indications for p16/Ki-67 in cervical cytology].Good performance of p16/ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN.p16/Ki-67 dual-stained cytology for detecting cervical (pre)cancer in a HPV-positive gynecologic outpatient population.Carcinogenic human papillomavirus infection.A cocktail of p16INK4a and Ki-67, p16INK4a and minichromosome maintenance protein 2 as triage tests for human papillomavirus primary cervical cancer screening.EpCAM expression in squamous cell carcinoma of the uterine cervix detected by monoclonal antibody to the membrane-proximal part of EpCAM.Human papillomavirus E7 protein detection as a method of triage to colposcopy of HPV positive women, in comparison to genotyping and cytology. Final results of the PIPAVIR study.Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.Protocol for Compass: a randomised controlled trial of primary HPV testing versus cytology screening for cervical cancer in HPV-unvaccinated and vaccinated women aged 25-69 years living in Australia.A novel metric that quantifies risk stratification for evaluating diagnostic tests: The example of evaluating cervical-cancer screening tests across populations.Human Papillomavirus DNA methylation as a biomarker for cervical precancer: Consistency across 12 genotypes and potential impact on management of HPV-positive women.RE: p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women.Identifying populations most susceptible to get benefit from broadening the scope for prevention of cervical cancer: Example from Uruguay.Comparison of human papillomavirus genotyping and cytology triage, COMPACT Study: Design, methods and baseline results in 14 642 women.Equal Management of Equal Risks: What Should be Used as the Standard for Cervical Cancer Prevention?
P2860
Q30239987-7EE7C3B2-D7D0-4728-A52B-D239C27DB005Q36407125-5F17D151-A5D8-4D73-8A72-275C0DA01DABQ36679896-0177FC27-57EE-4CE7-8813-14B93B6B68F7Q36994655-1F9364C3-52E4-45CC-8EB9-88443C32BA40Q38372386-A4921D2C-FD85-4E30-A50A-14F258B4FE53Q38706590-FAD2BB1A-B301-4F74-BA02-F9F6BD5FAE49Q38824019-FEE0901F-4148-404D-A902-44EEA9148AFCQ38837737-B7A98A6B-6430-4B2F-9D4E-973B630D35F5Q40096622-300CE605-254E-486A-AF2C-6B3B680186CCQ40129828-9D065FA8-574C-4AFA-BF07-5E5AEB7AE053Q40162758-FEED3D5B-45A3-4E0A-9FA0-859C756C26BCQ40202976-C988A04C-56D7-437D-87EF-EAD5C35D9C44Q40373166-11777B7A-80C4-43D9-834F-49A18B5C5A44Q40525853-B9C4F22C-A1B5-4246-9BB5-932D6531EBD2Q40767169-B61A37EC-B6EB-4338-8F73-25F36311CA92Q44863515-EA222FDA-6DFF-44C6-8A66-8DFA155EB7D8Q45746736-CA3053B9-A536-40BA-9F8D-8413CB3D9A5FQ47119583-1EBAF8CE-0942-45CD-9139-664B86C3AE67Q47790765-1180B43F-C13F-453D-9365-348492162853Q48110805-D54069CA-C4FD-40B9-9C9F-AF52190572E1Q49644195-BF503FCB-E931-46A6-91BB-FA3BC9320013Q49904079-DA092F54-98BC-49BC-98BF-B8CB1F174E0EQ50115891-1EEA209F-1855-4057-877F-D4890B9143F5Q50918970-F34122DC-F3BB-43D1-9196-4DF83D108070Q51738224-714B72DB-3EBE-4299-B7ED-5F3A42F7D889Q52585308-AC9B0AF6-CA64-47B4-86BA-711BF87498AAQ55618684-ADCA57E5-3289-4E96-A70D-0D471171DEA9
P2860
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@ast
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@en
type
label
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@ast
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@en
prefLabel
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@ast
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@en
P2093
P2860
P356
P1476
p16/Ki-67 Dual Stain Cytology for Detection of Cervical Precancer in HPV-Positive Women
@en
P2093
Barbara Fetterman
Clara Bodelon
Diane Tokugawa
Eric Stiemerling
Nancy Poitras
Philip E Castle
Shannon N Wood
Thomas Lorey
Walter Kinney
P2860
P304
P356
10.1093/JNCI/DJV257
P407
P577
2015-09-15T00:00:00Z